Office-based opioid treatment (OBOT) provider ARS Treatment Centers has opened three new facilities at Hamburg, Lanoka Harbor, and Pennsauken in New Jersey, the US.
With these latest openings, ARS currently operates 50 OBOT centres in five US states – Kentucky, New Jersey, Pennsylvania, Tennessee and Virginia.
ARS Treatment Centers director of integrative medicine Dr Kevin Moore said: “New Jersey has been hit incredibly hard by the opioid crisis. Data suggests that the heroin overdose rate in the state is three times the national average and that, through June 30, 2019, there have already been 1,387 suspected overdose-related deaths. This is tragic and unacceptable.
“Our team is committed to bringing dedicated resources to the state to ensure that limited access to comprehensive treatment is no longer a barrier to recovery for patients. We look forward to working with state and community leaders to tackle this crisis head-on.”
At these centres, patients are seen based on appointments only.
ARS accepts most insurance plans, including Medicaid.
ARS, which is headquartered in Greenville, South Carolina, is a subsidiary of Crossroad Treatment Centers.
Crossroad operates 80 treatment centres in ten states.
ARS provides personalised treatment plans which include medication, counselling and toxicology services to its patients.
Serving 20,000 patients each month, ARS plans to open 20 more facilities in 2019 to tackle the opioid issue in the US.
